Judge Refuses To Lift Ban On Generic Lovenox

Law360, New York (December 2, 2011, 7:11 PM EST) -- A Massachusetts federal judge on Friday refused a request from Watson Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc. and International Medical Systems Ltd. to quash an injunction barring the drugmakers from  competing with Momenta Pharmaceuticals Inc.’s generic version of Sanofi SA's blood-thinning drug Lovenox in the U.S.

U.S. District Judge Nathaniel M. Gorton denied the drugmakers’ emergency motion for relief from the preliminary injunction, citing a Nov. 23 memorandum and order denying a similar request.

“The court concludes that defendants have not met their burden to obtain a...
To view the full article, register now.